Beyond the Percentage: What HPLC Purity Data Can and Cannot Prove Before a Reproducibility Review
A reproducibility review asks a blunt question: if another group opened a different vial from a different batch and followed the same protocol, would they record the same result? The high-performance liquid chromatography (HPLC) purity figure on the certificate of analysis (CoA) is usually the first number quoted in answer. It is a genuinely useful gate, but it is a narrow one. A percentage describes one measurement, made under one set of chromatographic conditions, on one submitted sample. It does not describe identity, net peptide content, elemental contamination or the molarity a bench worker will actually pipette into an in-vitro assay. Understanding that boundary before a review begins is what separates a defensible provenance record from a hopeful one.
What the Purity Percentage Actually Measures
Most peptide CoAs report purity as an area percentage from reversed-phase HPLC with ultraviolet detection, commonly at 214 or 220 nanometres, where the peptide backbone absorbs. The peak of interest is expressed as a share of total integrated peak area. That number is a statement about a chromatogram, not a statement about a substance. It says that, under the specified column chemistry, mobile phase composition, gradient, flow rate, wavelength and integration threshold, the predominant peak accounted for the stated proportion of the detected signal.
Change any of those parameters and the figure can move without the material changing at all. Peaks that fall below the integration threshold are not counted. Species that co-elute are not resolved and are therefore absorbed into the main peak. UV response factors differ between a peptide and its impurities, so area percentage is not mass percentage; a truncated sequence, an oxidised variant or a diastereomer may carry a different extinction coefficient from the target molecule. A method that reports 99.1% has told you that the separation worked well enough to resolve most UV-absorbing material, and little more than that.
Equally important is what the detector cannot see. Non-UV-active material passes through the system without registering: counter-ions such as trifluoroacetic acid, inorganic salts, residual water and residual solvents. The shop’s FAQs state that its peptides contain trace amounts of mannitol, an excipient used to support lyophilisation, solubility and stability in storage. Mannitol contributes to the mass in the vial but not to the HPLC purity figure, which is one reason a certificate and a microbalance can appear to disagree during a review of weighed quantities.
Nor does a purity percentage screen for elemental impurities or endotoxin, and nor does it confirm sequence. A single clean peak demonstrates that one predominant species elutes at the expected retention time under those conditions; it does not demonstrate that the species is the peptide named on the label. That is why the shop describes full-spectrum testing across purity, identity, heavy metals and endotoxin evaluation of submitted samples, with the CoA serving as the document that pulls those separate data streams together for a batch.
Identity, Excipients and the Contaminants the Figure Cannot Cover
Two vials can both read 99% and still deliver materially different amounts of peptide to an assay. Net peptide content, water content, counter-ion load and excipient mass all sit between the certificate and the balance. Where a review is comparing molarity across batches — or across suppliers — the working record should capture the weighed mass, the stated content basis and the diluent volume used in the in-vitro workflow, rather than the purity figure alone. Purity is a ratio; content is an amount. Confusing the two is one of the most common reasons a protocol reproduces on paper and fails at the plate reader.
Contamination screening is a separate exercise with separate methods. Inductively coupled plasma mass spectrometry for elemental impurities and compendial endotoxin testing are not HPLC measurements and cannot be inferred from a chromatogram. When the shop’s documentation refers to heavy metals and endotoxin evaluation, those results belong to a distinct analytical stream that should be read alongside the purity value, not distilled into it.
Provenance adds another layer. The FAQs note that restocked products may carry the same Internal Test Reference (ITR) as earlier stock; an ITR links to the associated sample testing reports but does not confirm that separate deliveries come from the same production lot or that they have been independently tested separately. Vial cap colours and other packaging details may vary and are not an indicator of identity, analytical quality or manufacturing origin. What does tie a physical vial to a document is the label reference, which combines the SKU code and expiry date, for example BPC10-03/27. That reference, quoted in correspondence about documentation, is the practical anchor for any review file.
Materials managers comparing Uk peptides supplier documentation should therefore check three things on arrival: that the CoA presented matches the vial label reference exactly, that the methods listed address the specific question the review is asking, and that the ITR on the document corresponds to the stock actually received rather than an earlier delivery of the same catalogue line.
Turning the Certificate into Reproducibility Evidence
The review panel will want an unbroken chain from document to result. Begin with the label reference and record it in the laboratory notebook alongside the CoA revision, the receipt date and the storage history of the vial. Handling records matter as much as analytical ones: the shop’s guidance is to store lyophilised peptides at –20°C or below, sealed with desiccant and protected from moisture, heat and light; to allow vials to reach room temperature before opening; and to avoid repeated freeze–thaw cycles. Reconstituted material is less stable and should be held at 2–8°C for short-term laboratory use. Recording the diluent volume and resulting concentration for an in-vitro assay makes the preparation reproducible by a second operator; the site’s reconstitution calculator is a laboratory aid only and must not be used for human or veterinary dosing.
Purchasing figures deserve the same scrutiny as analytical ones. The homepage currently publishes lines such as “≥99% Verified Purity”, “UK Research Materials Over 99.1% Purity”, “3,000+ UK Orders”, “24hr UK Delivery” and “CoAs Janoshik Analytical Reports”. These are the supplier’s own published wording at the time of reading and should be reconfirmed against the live site, and — more importantly — against the batch CoA supplied with the specific vial. Fulfilment is described as next-working-day dispatch via Royal Mail Tracked 24, a carrier estimate rather than a guarantee, so ordering timelines belong in the methods schedule: a reproducibility run compromised by a mid-protocol gap in material is a methodological variable, not an inconvenience.
Finally, the compliance boundary is part of the record. All materials from the shop are supplied strictly for controlled laboratory and analytical research, are not for human or veterinary use, and are labelled “For Research Use Only – Not for Human Consumption” as the shop’s stated position, in line with MHRA guidance as described on the site. The purchaser is responsible for lawful use, safe handling, storage and disposal under COSHH and relevant UK laboratory safety standards, and for confirming that a given material suits the intended in-vitro application. A review file that documents the lot, the label reference, the analytical methods relied upon and the handling history converts a purity percentage from a headline into evidence — and leaves the reviewer asking the only question that matters: could this experiment be repeated, from this documentation, in another laboratory?
Born in Kochi, now roaming Dubai’s start-up scene, Hari is an ex-supply-chain analyst who writes with equal zest about blockchain logistics, Kerala folk percussion, and slow-carb cooking. He keeps a Rubik’s Cube on his desk for writer’s block and can recite every line from “The Office” (US) on demand.